These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16325930)

  • 1. Citrate-mediated disaggregation of rotavirus particles in RotaTeq vaccine.
    Peterson SE; Wang S; Ranheim T; Owen KE
    Antiviral Res; 2006 Feb; 69(2):107-15. PubMed ID: 16325930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and biological characterization of the 5 human-bovine rotavirus (WC3)-based reassortant strains of the pentavalent rotavirus vaccine, RotaTeq.
    Matthijnssens J; Joelsson DB; Warakomski DJ; Zhou T; Mathis PK; van Maanen MH; Ranheim TS; Ciarlet M
    Virology; 2010 Aug; 403(2):111-27. PubMed ID: 20451234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation.
    Clark HF; Burke CJ; Volkin DB; Offit P; Ward RL; Bresee JS; Dennehy P; Gooch WM; Malacaman E; Matson D; Walter E; Watson B; Krah DL; Dallas MJ; Schödel F; Kaplan kM; Heaton P
    Pediatr Infect Dis J; 2003 Oct; 22(10):914-20. PubMed ID: 14551493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and application of a quantitative RT-PCR potency assay for a pentavalent rotavirus vaccine (RotaTeq).
    Ranheim T; Mathis PK; Joelsson DB; Smith ME; Campbell KM; Lucas G; Barmat S; Melissen E; Benz R; Lewis JA; Chen J; Schofield T; Sitrin RD; Hennessey JP
    J Virol Methods; 2006 Feb; 131(2):193-201. PubMed ID: 16214228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.
    Vesikari T; Clark HF; Offit PA; Dallas MJ; DiStefano DJ; Goveia MG; Ward RL; Schödel F; Karvonen A; Drummond JE; DiNubile MJ; Heaton PM
    Vaccine; 2006 May; 24(22):4821-9. PubMed ID: 16621194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of an ideal rotavirus vaccine.
    Reisinger KS; Block SL
    Clin Pediatr (Phila); 2008 Jul; 47(6):555-63. PubMed ID: 18467670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a pentavalent rotavirus vaccine against prevalent serotypes of rotavirus gastroenteritis.
    Heaton PM; Goveia MG; Miller JM; Offit P; Clark HF
    J Infect Dis; 2005 Sep; 192 Suppl 1():S17-21. PubMed ID: 16088800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotavirus immunoglobulin a responses stimulated by each of 3 doses of a quadrivalent human/bovine reassortant rotavirus vaccine.
    Ward RL; Bernstein DI; Smith VE; Sander DS; Shaw A; Eiden JJ; Heaton P; Offit PA; Clark HF
    J Infect Dis; 2004 Jun; 189(12):2290-3. PubMed ID: 15181577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccine.
    Goveia MG; Ciarlet M; Owen KE; Ranucci CS
    Ann N Y Acad Sci; 2011 Mar; 1222():14-8. PubMed ID: 21434938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sibling transmission of vaccine-derived rotavirus (RotaTeq) associated with rotavirus gastroenteritis.
    Payne DC; Edwards KM; Bowen MD; Keckley E; Peters J; Esona MD; Teel EN; Kent D; Parashar UD; Gentsch JR
    Pediatrics; 2010 Feb; 125(2):e438-41. PubMed ID: 20100758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines: the pentavalent rotavirus vaccine: discovery to licensure and beyond.
    Heaton PM; Ciarlet M
    Clin Infect Dis; 2007 Dec; 45(12):1618-24. PubMed ID: 18198497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants.
    Clark HF; Offit PA; Plotkin SA; Heaton PM
    Pediatr Infect Dis J; 2006 Jul; 25(7):577-83. PubMed ID: 16804425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RotaTeq: a three-dose oral pentavalent reassortant rotavirus vaccine.
    Chandran A; Santosham M
    Expert Rev Vaccines; 2008 Dec; 7(10):1475-80. PubMed ID: 19053204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants.
    Goveia MG; Rodriguez ZM; Dallas MJ; Itzler RF; Boslego JW; Heaton PM; DiNubile MJ;
    Pediatr Infect Dis J; 2007 Dec; 26(12):1099-104. PubMed ID: 18043445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation of rotavirus double-layered particles and triple-layered particles by capillary zone electrophoresis.
    Mathis PK; Ciarlet M; Campbell KM; Wang S; Owen KE; Ranheim TS
    J Virol Methods; 2010 Oct; 169(1):13-21. PubMed ID: 20599561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jan; 119(1):171-82. PubMed ID: 17200286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequency.
    Goveia MG; DiNubile MJ; Dallas MJ; Heaton PM; Kuter BJ;
    Pediatr Infect Dis J; 2008 Jul; 27(7):656-8. PubMed ID: 18520448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life.
    Block SL; Vesikari T; Goveia MG; Rivers SB; Adeyi BA; Dallas MJ; Bauder J; Boslego JW; Heaton PM;
    Pediatrics; 2007 Jan; 119(1):11-8. PubMed ID: 17200266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RotaTeq vaccine adverse events and policy considerations.
    Geier DA; King PG; Sykes LK; Geier MR
    Med Sci Monit; 2008 Mar; 14(3):PH9-16. PubMed ID: 18301365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.
    Ruiz-Palacios GM; Guerrero ML; Bautista-Márquez A; Ortega-Gallegos H; Tuz-Dzib F; Reyes-González L; Rosales-Pedraza G; Martínez-López J; Castañón-Acosta E; Cervantes Y; Costa-Clemens S; DeVos B
    Pediatrics; 2007 Aug; 120(2):e253-61. PubMed ID: 17606534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.